EYLEA®

When practices and medical professionals choose to purchase EYLEA®, they are selecting a leading treatment option in the management of several serious retinal conditions. 

EYLEA® (aflibercept) is an FDA-approved, versatile, and effective medication that has been extensively used and trusted in the field of ophthalmology, offering significant benefits for patients with specific eye diseases.

What Is EYLEA® Used For?

EYLEA® is utilized for the treatment of:

• Wet Age-Related Macular Degeneration (Wet AMD): It helps slow the progression of Wet AMD by inhibiting vascular endothelial growth factor (VEGF), a primary cause of abnormal blood vessel growth and leakage in the retina.
• Diabetic Macular Edema (DME): EYLEA® reduces swelling in the retina caused by DME, improving vision and preventing further vision loss.
• Diabetic Retinopathy (DR): In patients with DR, EYLEA® can reduce the risk of progression, helping to preserve vision.
• Macular Edema following Retinal Vein Occlusion (MEfRVO): It treats swelling and improves vision in patients who have macular edema following RVO.
• Retinopathy of Prematurity (ROP): EYLEA® is also indicated for the treatment of ROP in preterm infants, showcasing its broad applicability in retinal health.

By targeting and inhibiting VEGF, EYLEA® effectively manages these conditions, offering hope and improved outcomes for patients facing vision-threatening diseases.

How Long Does EYLEA® Last?

The duration of EYLEA®’s effectiveness varies based on the condition being treated. Typically, after an initial loading phase of monthly injections for the first three months, patients may transition to a maintenance phase where injections are administered every 8 weeks.

However, the treatment interval may be adjusted based on the patient’s response. In some cases, EYLEA® has allowed patients to extend the interval between doses up to 12 weeks, demonstrating its lasting efficacy in maintaining visual acuity and retinal health.

EYLEA® Administering Techniques

To ensure the best results, medical practitioners administering EYLEA® will go though the following steps:

• Patient Evaluation: Before administering EYLEA®, assess the patient’s medical history and conduct a thorough eye examination.
• Preparation: Ensure the EYLEA® vial is at the correct temperature and prepare the injection under aseptic conditions. Disinfect the periocular area to reduce the risk of infection.
• Anesthesia: Apply topical anesthesia to the eye to minimize discomfort during the injection process. 
• Injection: Administer EYLEA® via an intravitreal injection, carefully inserting the needle through the pars plana and delivering the medication into the vitreous humor.
• Monitoring: After the injection, monitor the patient for any immediate reactions or complications, such as increased intraocular pressure or signs of endophthalmitis.
• Post-Procedure Care: Provide the patient with post-injection care instructions, including signs of potential complications to watch for and when to seek immediate medical attention.
• Follow-Up: Schedule a follow-up appointment to assess the patient’s response to the treatment and determine the timing of subsequent injections.

EYLEA® Side Effects

While EYLEA® is a crucial medication for many patients, it comes with potential side effects, including:

• Eye redness and irritation: Common after injection, usually temporary.
• Increased intraocular pressure: A possible increase in the pressure inside the eye following the injection.
• Cataracts: A potential long-term side effect, particularly with repeated injections.
• Vitreous detachment: The gel-like substance inside the eye may pull away from the retina.
• Eye pain: Some patients may experience discomfort or pain post-injection.
• Endophthalmitis: A rare but serious infection inside the eye.
• Retinal detachment: An uncommon but severe condition where the retina separates from the back of the eye.

Patients should be monitored for these side effects and report any unusual symptoms to their healthcare provider immediately.

EYLEA® vs Competition

EYLEA® sets itself apart from competitors with its specific binding to VEGF, offering a potent blockade that is crucial for treating various retinal conditions. 

Its extended duration of action allows for less frequent dosing, enhancing patient convenience and compliance. 

Additionally, EYLEA® has demonstrated a robust safety profile and efficacy in multiple large-scale clinical trials, providing reliable outcomes for patients with retinal diseases compared to other treatments in its class.

Where Can I Buy EYLEA®?

You can purchase EYLEA® online from certified and reputable providers to ensure the authenticity and quality of the medication. 

Ensuring you obtain EYLEA® from trusted sources is crucial for the safety and success of patient treatments, aligning with the commitment to provide top-tier care in ophthalmology.

For healthcare facilities looking to purchase EYLEA® wholesale but not knowing where to look, our knowledgeable team can offer guidance and support to help them access the medication efficiently and at competitive pricing.